About Synaptogenix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from About Synaptogenix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In About Synaptogenix Today - Breaking & Trending Today

Synaptogenix Announces Publication of Peer-Reviewed Scientific Article Evidencing Byrostatin-1's Improved Cognition Over Baseline in Advanced Alzheimer's Disease Patients

Published: February 1, 2022

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for...

Source: prnewswire.com

Related Topics:

Robert WeinsteinExchange CommissionDrug AdministrationPrnewswire Synaptogenix IncSynaptogenix IncAdvanced AlzheimerAbout SynaptogenixHealth Supported PhaseOrphan Drug DesignationMedia Contact